On the recordSeptember 24, 2019
This committee has a history of working in a bipartisan manner to improve generic and biosimilar competition.
Source
congress.govEditor's note · Context
Burgess highlights the committee's past bipartisan efforts to enhance drug competition.
Share
More from Michael Burgess
Apr 19, 2024
I would just ask if the gentleman from Massachusetts has additional speakers. If not, I am prepared to close, and I reserve the balance of my time. Mr. McGOVERN. Mr. Speaker, I am prepared to close, and I yield myself the balance of my…
Jul 9, 2024
May I inquire as to how much time is remaining. The SPEAKER pro tempore. The gentleman from Texas has 12\1/2\ minutes remaining.
Jul 9, 2024
Yes, I am. Are you prepared to take notes? Mr. McGOVERN. Okay. I will give you copies of what I am saying so you can have them. Madam Speaker, I yield myself the balance of my time to close. Madam Speaker, at the end of the day, it is not…
Dec 4, 2024
I thank you for that admonition. I will try to be careful to keep that in mind during my closing remarks. Mr. Speaker, I yield myself the balance of my time. Mr. Speaker, the gentleman from Massachusetts is correct. He has provided me…
Other voices in this conversation
